logo
Monday - Friday: 8:00 AM - 7:30 PM Saturday: 8:00 AM - 1:30 PM

Alfarmakos was founded in 2005 and since then has been importing and distributing pharmaceutical products, dietary supplements, medical materials, and various other products.

    OUR SERVICES

    Regulatory & Pharmacovigilance​

    At Alfarmakos the Regulatory Affairs Department plays a pivotal role in ensuring regulatory compliance of medicines for human use, medical devices, cosmetics, and food supplements. Our team efficiently and accurately manages the registration process for the wide range of products, ensuring full compliance with both national regulations and EU regulations. Additionally, they carefully oversee the lifecycle of medications, managing renewals and variations promptly for all products involved, thus guaranteeing that the continuity and quality of their supply. Regulatory service is a key point for maintaining the relationship between partners and the national agency for medicines and medical devices (AKBPM) / Ministry of Health.

    For us, one of the key tasks is to provide consumers with high quality, effective and safe medicines, the benefits of which exceed potential risks. To monitor the safety and effectiveness of our medicines, we have established a Pharmacovigilance department. When detecting side effects, our specialists look for the cause of their occurrence and do everything necessary to minimize and prevent the recurrence of side effects in the future. We would appreciate any information regarding the detection of atypical manifestations, side effects, or the lack of efficiency in the use of medicines. The information you provide is strictly confidential and is not subject to disclosure, except in cases established by law. Below is a form to be filled out. All fields are required. If any information is unknown to you, please specify it in the corresponding field.

    report

    Report Adverse EVENTS

    Any adverse event you experience while using a product, whether listed in the package insert or not, should be reported. If you encounter any side effects, please reach out to our pharmacovigilance team using the contact details below.